AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 41 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q2 2022 | $727,000 | -99.2% | 1,136 | -96.7% | 0.00% | – |
| Q1 2022 | $90,854,000 | +46.4% | 34,810 | +118.2% | 0.00% | – |
| Q4 2021 | $62,046,000 | +12065.9% | 15,950 | +13532.5% | 0.00% | – |
| Q3 2021 | $510,000 | -41.8% | 117 | -47.1% | 0.00% | – |
| Q2 2021 | $877,000 | -93.2% | 221 | -91.1% | 0.00% | – |
| Q1 2021 | $12,974,000 | -27.9% | 2,495 | -25.8% | 0.00% | – |
| Q4 2020 | $17,992,000 | -12.8% | 3,363 | -20.9% | 0.00% | – |
| Q3 2020 | $20,634,000 | +470.6% | 4,250 | +471.2% | 0.00% | – |
| Q2 2020 | $3,616,000 | +3552.5% | 744 | +1553.3% | 0.00% | – |
| Q1 2020 | $99,000 | -62.2% | 45 | 0.0% | 0.00% | – |
| Q4 2019 | $262,000 | -94.1% | 45 | -96.8% | 0.00% | – |
| Q3 2019 | $4,449,000 | -24.3% | 1,399 | 0.0% | 0.00% | – |
| Q2 2019 | $5,876,000 | -65.8% | 1,399 | -43.8% | 0.00% | – |
| Q1 2019 | $17,199,000 | – | 2,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
| WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
| Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |